Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9435 |
High Similarity |
NPD3027 |
Phase 3 |
0.9048 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8968 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8915 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8915 |
High Similarity |
NPD1613 |
Approved |
0.8819 |
High Similarity |
NPD3018 |
Phase 2 |
0.8655 |
High Similarity |
NPD228 |
Approved |
0.8651 |
High Similarity |
NPD2982 |
Phase 2 |
0.8651 |
High Similarity |
NPD2983 |
Phase 2 |
0.8571 |
High Similarity |
NPD2981 |
Phase 2 |
0.8361 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8359 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.832 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8203 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8195 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8116 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.8082 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8043 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.8041 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8033 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8033 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7985 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7941 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7939 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7905 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7902 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7803 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7786 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7761 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD940 |
Approved |
0.775 |
Intermediate Similarity |
NPD846 |
Approved |
0.7704 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7681 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7681 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7681 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7664 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7639 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD37 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7557 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7548 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD7054 |
Approved |
0.752 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7519 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7519 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7481 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD1607 |
Approved |
0.744 |
Intermediate Similarity |
NPD290 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD943 |
Approved |
0.7422 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7415 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD3145 |
Approved |
0.741 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7395 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7395 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7395 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7385 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7383 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7379 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7376 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7361 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7353 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD9494 |
Approved |
0.731 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7295 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7256 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7239 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD968 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7211 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7211 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7192 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD5090 |
Approved |
0.719 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7183 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7121 |
Intermediate Similarity |
NPD709 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7111 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7111 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7103 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.708 |
Intermediate Similarity |
NPD2233 |
Approved |
0.708 |
Intermediate Similarity |
NPD2232 |
Approved |
0.708 |
Intermediate Similarity |
NPD2230 |
Approved |
0.707 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7049 |
Intermediate Similarity |
NPD844 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.704 |
Intermediate Similarity |
NPD291 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6896 |
Approved |
0.703 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7023 |
Intermediate Similarity |
NPD5535 |
Approved |
0.702 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7013 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7007
|
Intermediate Similarity |
NPD5762 |
Approved |